Wednesday, March 21, 1990 Attorney will wait to file Gathers suit
By Rachel Shuster
The attorney for the family of Loyola Marymount basketball star Hank Gathers, who
collapsed and died during a game March 4, said he won’t file any lawsuit until the NCAA tournament ends April 2.
“If somebody is liable for Hank’s death, we can wait,” said Bruce Fagel, the attorney-
physician representing Gathers’ family, “even if Loyola is out of the tournament, which I hope not.
“I do not want to do anything to hurt Hank’s teammates. Hank would not have wanted
But Fagel still is investigating grounds for a lawsuit in Los Angeles Superior Court. The
• Why was Gathers, who first fainted during a Dec. 9 game and diagnosed with
heart rhythm irregularities, started on a high dose of Inderal (240 milligrams) when medication often is gradually added?
• Why was Gathers allowed to play such a strenuous sport without more time to
monitor his reactions to the medication?
Fagel cited a 1984 study on cardiovascular abnormalities in athletes from
the American College of Cardiology that would have recommended Gathers “not engage in any competitive sports.”
• Why was a courtside defibrillator, for resuscitating the heart, not used, especially
when the attached monitor would have given a reading on Gathers’ heartbeats?
The answers to some of those questions are in medical records that Fagel said remain
Of particular interest are notes on the reductions of Gathers’ Inderal dose. The Los Angeles County Coroner’s office ruled Gathers did not have enough Inderal in
his system to treat his irregular heartbeat.
“I’m concerned about the last couple of reductions,” Fagel said. “Hank’s medication was
reduced, his play dramatically improved and he was satisfied. Yet the medication was reduced again.”
Not, Fagel said, at Gathers’ request: “Hank didn’t do that. He followed his physician’s
advice. If he had stopped taking it, nothing would have shown up in the autopsy.
“This is not a simple doctor-patient relationship. There’s a third party — the school.
That’s why I need to get some more information.”
Athletic director Brian Quinn, meanwhile, is not commenting on Gathers’ case. Nor is the university releasing its tape of the game in which Gathers died. Fagel wants that tape, as well as unedited versions from three Los Angeles TV stations,
to see what happened to Gathers and what people did or did not do to help.
“I will go to the Supreme Court, if I have to, to get the game tape from Loyola. They’re
the defendants,” Fagel said. “I hope I don’t need to go to the Supreme Court against the news organizations.
“They are taking the same position as the president, that everything is privileged, that
unedited tapes are covered just like reporters’ notes. But this raises a very interesting conflict, because the public wants to know what’s going on.”
• Medical background:
M.D., University of Illinois-Chicago College of Medicine;
practiced emergency-room medicine for 10 years.
• Law background:
J.D., Whittier College; passed California bar in 1982 and
opened law office in Beverly Hills; primarily handles obstetrical cases involving injuries to children at birth.
• Member, American College of Legal Medicine:
755 members with dual
degrees; only about 50 are practicing trial attorneys.
• Change from medicine to law:
“I was disturbed with what I was seeing in
emergency medicine. On many occasions, I was left holding the patient without the appropriate backup … I went into law, which is more intellectually challenging.”
• Gathers’ case:
Friend of family contacted Fagel day after the player’s death.
FOR IMMEDIATE RELEASE THE GORES GROUP COMPLETES THE ACQUISITION OF THERAKOS, INC. FROM ORTHO-CLINICAL DIAGNOSTICS, INC. LOS ANGELES, JANUARY 2, 2013 – The Gores Group, a global investment firm focused on acquiring controlling interests in mature and growing businesses, today announced that it has completed the acquisition of Therakos, Inc. from Ortho-Clinical Diagnostics, Inc
“GIU’ LE MANI DAI BAMBINI®” CAMPAGNA NAZIONALE PER LA DIFESA DEL DIRITTO ALLA SALUTE DEI BAMBINI COMUNICATO STAMPA 26/04/05 Interdetta dall’Agenzia Europea per i Medicinali (EMEA) la somministrazione di psicofarmaci antidepressivi a bambini ed adolescenti: favoriscono il suicidio nel minori L’Agenzia Europea per il Farmaco (EMEA) ha terminato gli s